Transversus Abdominus Plane Block in Living Donor Hepatectomy

AlRefaey Kandeel90 enrolled

Overview

Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug

Transversus abdominus plane block for postoperative analgesia after donor hpatectomy surgery using three different drugs control group, Bupivecaine group, and Dexmedetomedine group

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Living Donor Hepatectomy

Interventions

surgically inserted Transversus abdominus plane catheterDEVICE

at end of surgery, a surgeon will insert catheter in Transversus abdominus plane (TAP) between internal oblique muscle and Transversus abdominus muscle

Intravenous morphineDRUG

Boluses of intravenous morphine (2 mg) will be given to patients if Visual analogue scale (VAS) more than 3

BupevecaineDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all living hepatectomy donors in Mansoura liver transplantation program Exclusion Criteria: * refusal known sensetivity to used drugs

Locations (2)

Mansoura university

Al Mansurah, Dakahlia Governorate, Egypt

Mansoura university

Al Mansurah, Dkahleya, Egypt

Outcomes

Primary Outcomes

postoperative morphine (mg) consumption in 1st 48 hours

Time frame: 48 hours postoperative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.